These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
808 related articles for article (PubMed ID: 25739820)
41. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Brzozowska MM; Ostapowicz G; Weltman MD J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335 [TBL] [Abstract][Full Text] [Related]
42. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Cusi K Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374 [TBL] [Abstract][Full Text] [Related]
43. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Parekh S; Anania FA Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512 [TBL] [Abstract][Full Text] [Related]
44. Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications. Andronescu CI; Purcarea MR; Babes PA J Med Life; 2018; 11(1):20-23. PubMed ID: 29696060 [TBL] [Abstract][Full Text] [Related]
45. The molecular mechanisms between metabolic syndrome and breast cancer. Chen Y; Wen YY; Li ZR; Luo DL; Zhang XH Biochem Biophys Res Commun; 2016 Mar; 471(4):391-5. PubMed ID: 26891869 [TBL] [Abstract][Full Text] [Related]
46. Hype or Reality: Should Patients with Metabolic Syndrome-related NAFLD be on the Hunter-Gatherer (Paleo) Diet to Decrease Morbidity? Tarantino G; Citro V; Finelli C J Gastrointestin Liver Dis; 2015 Sep; 24(3):359-68. PubMed ID: 26405708 [TBL] [Abstract][Full Text] [Related]
47. Response to 'Effect of metabolic components on incident type 2 diabetes mellitus in nonalcoholic fatty liver disease subjects'. Fukuda T; Hamaguchi M; Fukui M Liver Int; 2016 Mar; 36(3):462. PubMed ID: 26442842 [No Abstract] [Full Text] [Related]
48. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease. Catanzaro R; Cuffari B; Italia A; Marotta F World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349 [TBL] [Abstract][Full Text] [Related]
50. The Framingham Heart Study--67 years of discovery in metabolic disease. Long MT; Fox CS Nat Rev Endocrinol; 2016 Mar; 12(3):177-83. PubMed ID: 26775764 [TBL] [Abstract][Full Text] [Related]
51. Quality of life in patients with nonalcoholic fatty liver disease in combination with essential hypertension considering taste sensitivity to sodium chloride. Mashura HY; Hanych TM; Rishko AA Wiad Lek; 2016; 69(2 Pt 2):204-7. PubMed ID: 27487534 [TBL] [Abstract][Full Text] [Related]